Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties

Author:

Poletto Mattia1,Malfatti Matilde C.1,Dorjsuren Dorjbal2,Scognamiglio Pasqualina L.34,Marasco Daniela3,Vascotto Carlo1,Jadhav Ajit2,Maloney David J.2,Wilson David M.5,Simeonov Anton2,Tell Gianluca1

Affiliation:

1. Department of Medical and Biological Sciences; University of Udine; Udine Italy

2. NIH Chemical Genomics Center; National Center for Advancing Translational Sciences; National Institutes of Health; Bethesda Maryland

3. Department of Pharmacy; CIRPEB (Centro Interuniversitario di Ricerca sui Peptidi Bioattivi); University of Naples ‘Federico II’; Naples Italy

4. Center for Advanced Biomaterials for Healthcare@CRIB; Istituto Italiano di Tecnologia (IIT); Naples Italy

5. Laboratory of Molecular Gerontology; National Institute on Aging; National Institutes of Health; Baltimore Maryland

Funder

National Institutes of Health

Associazione Italiana per la Ricerca sul Cancro (AIRC)

Crossborder cooperation program Italy- Slovenia 2007- 2013 funded by the European Regional development Fund (ERDF) and the National Funds, implemented by the Autonomous Region Friuli Venezia Giulia, in quality of Managing Authority

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3